Abdullah AlSaleh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdullah AlSaleh has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Eman Farid
Department of Microbiology, Immunology and Infectious Diseases, College of Medicine and Health Sciences, Arabian Gulf University
8 shared publicationsKhalid Bindayna
Department of Microbiology, Immunology and Infectious Diseases, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
6 shared publicationsMohammed Shahid
Microbiology, Immunology and Infectious Diseases Dept., College of Medicine and Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain
6 shared publicationsNermin Kamal
AlSalmaniya Medical Complex, Microbiology Laboratory, Manama, Bahrain
4 shared publications- Mohammad Shahid
Department of Microbiology, Immunology, and Infectious Diseases, College of Medicine & Medical Sciences, Arabian Gulf University, Bahrain
2 shared publications - Ali Al-Mahmeed
Department of Microbiology, Immunology & Infectious Diseases, College of Medicine and Health Sciences, Arabian Gulf University, Manama 329, Bahrain
1 shared publication
Latest Publications
- Open Access
- 28 October 2026
- Published by MDPI AG in Microorganisms
- Vol. 14  (11) , 2463
Antimicrobial Potential of Culturable Soil Bacteria from the Kingdom of Bahrain
The global rise of antimicrobial resistance has intensified the search for new antibacterial agents from natural environments. Soil microbial communities have historically served as important reservoirs of bioactive metabolites, yet many regions remain insufficiently explored. This study surveyed soil samples across the Kingdom of Bahrain to identify culturable bacterial isolates exhibiting inhibitory activity against clinically relevant Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli (ESKAPEE) pathogens and to taxonomically characterize active isolates using 16S ribosomal RNA (rRNA) gene sequencing. A total of 45 soil samples were collected from diverse locations across the country. Culturable bacteria were isolated using standard microbiological methods and screened for antimicrobial activity using a competition plate assay against reference strains representing the ESKAPEE group of pathogens. Isolates demonstrating reproducible antagonistic activity were subsequently subjected to molecular identification through amplification and sequencing of the 16S rRNA gene. Screening revealed that 65 isolates exhibited consistent inhibitory activity against at least one ESKAPEE pathogen. Taxonomic analysis revealed a phylogenetically diverse collection of bacteria spanning multiple genera and phyla, including members of Bacillota, Pseudomonadota, and Bacteroidota. Several isolates belonged to well-known antimicrobial-producing lineages such as Bacillus and related Bacillaceae genera, while others represented comparatively underexplored environmental taxa, including Rossellomorea, Paenibacillus, Photobacterium, and Olivibacter. The observed antagonistic activity likely reflected diverse ecological strategies. Collectively, these findings demonstrated that soil microbiota from the Kingdom of Bahrain harbor diverse culturable bacteria with antibacterial activity against clinically important pathogens, providing an initial collection of antagonistic soil isolates for further characterization.
- 28 October 2026
- Published by MDPI AG in Microorganisms
- Vol. 14  (11) , 2463
Open AccessAntimicrobial Potential of Culturable Soil Bacteria from the Kingdom of Bahrain
The global rise of antimicrobial resistance has intensified the search for new antibacterial agents from natural environments. Soil microbial communities have historically served as important reservoirs of bioactive metabolites, yet many regions remain insufficiently explored. This study surveyed soil samples across the Kingdom of Bahrain to identify culturable bacterial isolates exhibiting inhibitory activity against clinically relevant Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli (ESKAPEE) pathogens and to taxonomically characterize active isolates using 16S ribosomal RNA (rRNA) gene sequencing. A total of 45 soil samples were collected from diverse locations across the country. Culturable bacteria were isolated using standard microbiological methods and screened for antimicrobial activity using a competition plate assay against reference strains representing the ESKAPEE group of pathogens. Isolates demonstrating reproducible antagonistic activity were subsequently subjected to molecular identification through amplification and sequencing of the 16S rRNA gene. Screening revealed that 65 isolates exhibited consistent inhibitory activity against at least one ESKAPEE pathogen. Taxonomic analysis revealed a phylogenetically diverse collection of bacteria spanning multiple genera and phyla, including members of Bacillota, Pseudomonadota, and Bacteroidota. Several isolates belonged to well-known antimicrobial-producing lineages such as Bacillus and related Bacillaceae genera, while others represented comparatively underexplored environmental taxa, including Rossellomorea, Paenibacillus, Photobacterium, and Olivibacter. The observed antagonistic activity likely reflected diverse ecological strategies. Collectively, these findings demonstrated that soil microbiota from the Kingdom of Bahrain harbor diverse culturable bacteria with antibacterial activity against clinically important pathogens, providing an initial collection of antagonistic soil isolates for further characterization.
- Open Access
- 16 October 2026
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 13, 1963030
Do fungal pathogens exploit HLA-G-mediated immune tolerance?
Fungal pathogens employ diverse strategies to evade host immunity and establish persistent infection, yet the contribution of immune checkpoint pathways to fungal pathogenesis remains incompletely understood. Human leukocyte antigen-G (HLA-G) is a nonclassical major histocompatibility complex class I molecule with potent immunoregulatory properties. It is capable of suppressing innate and adaptive immune responses through interactions with inhibitory receptors. Although HLA-G-mediated immune tolerance is increasingly recognized in cancer, transplantation, and persistent viral and parasitic infections, its role in fungal disease remains largely unexplored. This review examines the hypothesis that fungal pathogens may exploit HLA-G-mediated immune tolerance to facilitate infection and persistence. Particular attention is given to interleukin-10 and transforming growth factor-β, two immunoregulatory cytokines linked to HLA-G expression that are prominently induced during various fungal infections. The convergence of these pathways provides a mechanistic framework connecting fungal-induced immune regulation with potential HLA-G activity. Establishing this relationship could reveal an underrecognized mechanism of fungal immune evasion and identify opportunities for host-directed therapy.
- 16 October 2026
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 13, 1963030
Open AccessDo fungal pathogens exploit HLA-G-mediated immune tolerance?
Fungal pathogens employ diverse strategies to evade host immunity and establish persistent infection, yet the contribution of immune checkpoint pathways to fungal pathogenesis remains incompletely understood. Human leukocyte antigen-G (HLA-G) is a nonclassical major histocompatibility complex class I molecule with potent immunoregulatory properties. It is capable of suppressing innate and adaptive immune responses through interactions with inhibitory receptors. Although HLA-G-mediated immune tolerance is increasingly recognized in cancer, transplantation, and persistent viral and parasitic infections, its role in fungal disease remains largely unexplored. This review examines the hypothesis that fungal pathogens may exploit HLA-G-mediated immune tolerance to facilitate infection and persistence. Particular attention is given to interleukin-10 and transforming growth factor-β, two immunoregulatory cytokines linked to HLA-G expression that are prominently induced during various fungal infections. The convergence of these pathways provides a mechanistic framework connecting fungal-induced immune regulation with potential HLA-G activity. Establishing this relationship could reveal an underrecognized mechanism of fungal immune evasion and identify opportunities for host-directed therapy.
- Open Access
- 13 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20  (8) , e0329318
Dynamics of fungal bioaerosols in Kuwait City: An 8-year survey
Fungi are ubiquitous eukaryotic microorganisms that are often implicated in a wide range of diseases. Exposure to fungal bioaerosols is often associated with conditions such as asthma, allergic rhinitis, keratitis, and pneumonitis, among others. This study aims to shed some light on the configuration of airborne culturable fungal genera in the atmosphere of Kuwait City with analysis of seasonal patterns, intra-diurnal variations and correlations with meteorological factors. Outdoor fungal bioaerosols samples were collected twice a day, two times a week, from January 2016 to December 2023 via volumetric active sampling in Al-Sabah Medical District, Kuwait City, Kuwait. The meteorological data were supplied by Kuwait Meteorological Department, Directorate General of Civil Aviation. The rates of fungal bioaerosols remained relatively high during the months of March, April and May, ranging from 269 to 296 CFU/m3. Cladosporium, Aspergillus and Alternaria were the most common fungal genera in the atmosphere, with a prevalence of 49%, 16% and 14%, respectively. Statistically significant differences (p < 0.05) in fungal composition between intra-diurnal periods were demonstrated in most monthly analyses. A strong negative correlation was demonstrated with temperature and haze events. Conversely, positive correlations were observed with relative humidity, wind action, rainfall and dust phenotypes. Fungal dynamics in relation to seasonality and intra-diurnal variations require further elucidation. Collaborative research is needed to advance our understanding of the implications of elevated rates of fungal bioaerosols, the seasonality of specific fungal allergens and what may be suitable means of mitigation. Efforts such as this study will hopefully help facilitate regionally specific air quality management decisions and provide baseline information for health-care providers.
- 13 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20  (8) , e0329318
Open AccessDynamics of fungal bioaerosols in Kuwait City: An 8-year survey
Fungi are ubiquitous eukaryotic microorganisms that are often implicated in a wide range of diseases. Exposure to fungal bioaerosols is often associated with conditions such as asthma, allergic rhinitis, keratitis, and pneumonitis, among others. This study aims to shed some light on the configuration of airborne culturable fungal genera in the atmosphere of Kuwait City with analysis of seasonal patterns, intra-diurnal variations and correlations with meteorological factors. Outdoor fungal bioaerosols samples were collected twice a day, two times a week, from January 2016 to December 2023 via volumetric active sampling in Al-Sabah Medical District, Kuwait City, Kuwait. The meteorological data were supplied by Kuwait Meteorological Department, Directorate General of Civil Aviation. The rates of fungal bioaerosols remained relatively high during the months of March, April and May, ranging from 269 to 296 CFU/m3. Cladosporium, Aspergillus and Alternaria were the most common fungal genera in the atmosphere, with a prevalence of 49%, 16% and 14%, respectively. Statistically significant differences (p < 0.05) in fungal composition between intra-diurnal periods were demonstrated in most monthly analyses. A strong negative correlation was demonstrated with temperature and haze events. Conversely, positive correlations were observed with relative humidity, wind action, rainfall and dust phenotypes. Fungal dynamics in relation to seasonality and intra-diurnal variations require further elucidation. Collaborative research is needed to advance our understanding of the implications of elevated rates of fungal bioaerosols, the seasonality of specific fungal allergens and what may be suitable means of mitigation. Efforts such as this study will hopefully help facilitate regionally specific air quality management decisions and provide baseline information for health-care providers.
- Open Access
- 23 February 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25  (1) , 1-14
Non-Candida mycosis in Gulf Cooperation Council (GCC) countries: perspective of a low-incidence region
Background: Fungal pathogens are ubiquitous microorganisms that are implicated in a wide range of infections, affecting individuals with underlying health conditions and immune suppression therapy; however, immunocompetent individuals may also be at risk. Among these infections, many are caused by molds and yeasts other than Candida and are recognized in clinical practice, such as aspergillosis, mucormycosis, fusariosis, phaeohyphomycosis, and basidiobolomycosis, among others, each presents different clinical manifestations and requires clinical management specific to the site of involvement. Although pathogenic fungal contaminants and potential sources of mycosis in humans are plentiful in Gulf Cooperation Council (GCC) countries, epidemiological reports regarding mycosis in the region are scarce. Aim: The aim of this review is to shed some light on the epidemiology of clinically associated molds and yeasts other than Candida and to survey all related case reports and epidemiological studies conducted in the GCC over the past 10 years. Methods: A comprehensive search of the Medline (PubMed) and Scopus databases was conducted using the following keywords: Aspergillosis, Mycosis, Mucormycosis, Fusarium, Kuwait, Bahrain, Saudi Arabia, Qatar, Oman and the United Arab Emirates. A timeframe was set to include only articles that were published from 2014 to 2024. Results: One hundred thirty-five of the 1563 articles examined fulfilled the purpose of this review. Most studies were in Saudi Arabia (45%), Qatar (18%) and Kuwait (16%). Mucormycosis, aspergillosis, phaeohyphomycosis and basidiobolomycosis were among the most commonly reported fungal infections in the GCC, with corresponding mortality rates of 53%, 37%, 69% and 24%, respectively. The average estimations of non-Candida fungal infections indicate a low regional incidence in comparison with global estimations. Conclusion: Awareness and a high index of suspicion are warranted in successfully managing non-Candida mycosis. More specific immunological and molecular markers are needed for differential diagnosis to rule out fungal infections. Additionally, incorporating non-Candida mycosis-related antifungal resistance surveys in GCC national surveillance efforts should be enforced, especially when considering the increase in global mycosis rates.
- 23 February 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25  (1) , 1-14
Open AccessNon-Candida mycosis in Gulf Cooperation Council (GCC) countries: perspective of a low-incidence region
Background: Fungal pathogens are ubiquitous microorganisms that are implicated in a wide range of infections, affecting individuals with underlying health conditions and immune suppression therapy; however, immunocompetent individuals may also be at risk. Among these infections, many are caused by molds and yeasts other than Candida and are recognized in clinical practice, such as aspergillosis, mucormycosis, fusariosis, phaeohyphomycosis, and basidiobolomycosis, among others, each presents different clinical manifestations and requires clinical management specific to the site of involvement. Although pathogenic fungal contaminants and potential sources of mycosis in humans are plentiful in Gulf Cooperation Council (GCC) countries, epidemiological reports regarding mycosis in the region are scarce. Aim: The aim of this review is to shed some light on the epidemiology of clinically associated molds and yeasts other than Candida and to survey all related case reports and epidemiological studies conducted in the GCC over the past 10 years. Methods: A comprehensive search of the Medline (PubMed) and Scopus databases was conducted using the following keywords: Aspergillosis, Mycosis, Mucormycosis, Fusarium, Kuwait, Bahrain, Saudi Arabia, Qatar, Oman and the United Arab Emirates. A timeframe was set to include only articles that were published from 2014 to 2024. Results: One hundred thirty-five of the 1563 articles examined fulfilled the purpose of this review. Most studies were in Saudi Arabia (45%), Qatar (18%) and Kuwait (16%). Mucormycosis, aspergillosis, phaeohyphomycosis and basidiobolomycosis were among the most commonly reported fungal infections in the GCC, with corresponding mortality rates of 53%, 37%, 69% and 24%, respectively. The average estimations of non-Candida fungal infections indicate a low regional incidence in comparison with global estimations. Conclusion: Awareness and a high index of suspicion are warranted in successfully managing non-Candida mycosis. More specific immunological and molecular markers are needed for differential diagnosis to rule out fungal infections. Additionally, incorporating non-Candida mycosis-related antifungal resistance surveys in GCC national surveillance efforts should be enforced, especially when considering the increase in global mycosis rates.
- Open Access
- 7 April 2023
- Published by Springer Nature in Cureus
- Vol. 15  (4)
Multidrug-Resistant Staphylococcus aureus Isolates in a Tertiary Care Hospital, Kingdom of Bahrain
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a ubiquitous pathogen associated with a wide spectrum of human infections. In recent decades, MRSA infections have been increasingly reported in individuals without established risk factors, infecting immunocompetent members of the community. This emergence is attributed to the production of various virulence factors, notably Panton-Valentine leukocidin (PVL). Objective: The aim of this study was to better understand the prevalence, antibiotic resistance profiles, and molecular characteristics of S. aureus and MRSA in a tertiary care hospital in the Kingdom of Bahrain. Materials and methods: This cross-sectional study was carried out in a tertiary hospital for a one-year period, from December 2020 to December 2021. A total of 161 consecutive S. aureus isolates were collected. Antibiotic susceptibility was tested using BD Phoenixâ„¢ automated identification and susceptibility testing system. Molecular analysis was conducted via conventional PCR and conventional multiplex PCR for SCCmec typing. Results: In this study, 161 S. aureus isolates were investigated, 60% (n=97) were characterized as MRSA, of which, 12% (n=12) were healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) while 88% (n=85) were community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). No statistically significant difference (P>0.05) in antibiotic resistance trends between HA-MRSA and CA-MRSA was detected. Multidrug resistance (MDR) amounted to 19% (n=30) of all S. aureus isolates, 14% (n=9) of methicillin-susceptible Staphylococcus aureus (MSSA) isolates, and 22% (n=21) of MRSA isolates. SCCmec typing demonstrated a high prevalence of type IV (61%, n=59), followed by type V (32%, n=31), then type II (4%, n=4), and type III (3%, n=3). The PVL prevalence was 39% (n=25) in MSSA and 62% (n=60) in MRSA, 33% (n=4) in HA-MRSA, and 66% (n=56) in CA-MRSA. Conclusion: This study demonstrated the emergence of PVL-producing CA-MRSA in a tertiary care hospital, as well as the detection of PVL-producing MDR strains. This development prompts serious measures to be taken in order to sustain a healthy clinical environment.
- 7 April 2023
- Published by Springer Nature in Cureus
- Vol. 15  (4)
Open AccessMultidrug-Resistant Staphylococcus aureus Isolates in a Tertiary Care Hospital, Kingdom of Bahrain
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a ubiquitous pathogen associated with a wide spectrum of human infections. In recent decades, MRSA infections have been increasingly reported in individuals without established risk factors, infecting immunocompetent members of the community. This emergence is attributed to the production of various virulence factors, notably Panton-Valentine leukocidin (PVL). Objective: The aim of this study was to better understand the prevalence, antibiotic resistance profiles, and molecular characteristics of S. aureus and MRSA in a tertiary care hospital in the Kingdom of Bahrain. Materials and methods: This cross-sectional study was carried out in a tertiary hospital for a one-year period, from December 2020 to December 2021. A total of 161 consecutive S. aureus isolates were collected. Antibiotic susceptibility was tested using BD Phoenixâ„¢ automated identification and susceptibility testing system. Molecular analysis was conducted via conventional PCR and conventional multiplex PCR for SCCmec typing. Results: In this study, 161 S. aureus isolates were investigated, 60% (n=97) were characterized as MRSA, of which, 12% (n=12) were healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) while 88% (n=85) were community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). No statistically significant difference (P>0.05) in antibiotic resistance trends between HA-MRSA and CA-MRSA was detected. Multidrug resistance (MDR) amounted to 19% (n=30) of all S. aureus isolates, 14% (n=9) of methicillin-susceptible Staphylococcus aureus (MSSA) isolates, and 22% (n=21) of MRSA isolates. SCCmec typing demonstrated a high prevalence of type IV (61%, n=59), followed by type V (32%, n=31), then type II (4%, n=4), and type III (3%, n=3). The PVL prevalence was 39% (n=25) in MSSA and 62% (n=60) in MRSA, 33% (n=4) in HA-MRSA, and 66% (n=56) in CA-MRSA. Conclusion: This study demonstrated the emergence of PVL-producing CA-MRSA in a tertiary care hospital, as well as the detection of PVL-producing MDR strains. This development prompts serious measures to be taken in order to sustain a healthy clinical environment.
- Open Access
- 3 February 2023
- Published by Microbiology Society in Access Microbiology
- Vol. 5  (2) , 000475.v4
Synergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV methicillin-resistant Staphylococcus aureus (MRSA)
Background. Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogenic bacteria involved in a wide spectrum of human diseases. Many virulence factors promote this widespread propagation. One important factor is acquiring antibiotic resistance genes, which leads to a reduction in the availability and efficacy of therapy options. Recently, research has suggested that the remarkable antimicrobial effect of antioxidants against superbugs such as MRSA shows synergistic effects when accompanied by antimicrobial therapy. This paper aims to examine the synergistic effects of ascorbic acid and nicotinamide with a panel of antibiotics used in antimicrobial therapy against MRSA. Material and Methods. Two SCCmec type IV MRSA reference strains (EMRSA-15 and USA300) and 10 MRSA clinical isolates feature in this paper. SCCmec typing was conducted on the 10 clinical isolates via multiplex PCR after identification. Synergy experiments on antioxidants and antibiotics were evaluated via checkerboard assay. The minimum inhibitory concentration (MIC) of each agent was determined in accordance with the Clinical and Laboratory Standards Institute (CLSI) M100 guidelines through twofold microdilution assay. Results and Discussion. Synergy (FIC PConclusion. The synergistic activity demonstrated in associating antioxidants with antibiotics shows promise in managing superbugs. However, more research is required to better understand the mechanism of the synergy and for utilization in clinical care.
- 3 February 2023
- Published by Microbiology Society in Access Microbiology
- Vol. 5  (2) , 000475.v4
Open AccessSynergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV methicillin-resistant Staphylococcus aureus (MRSA)
Background. Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogenic bacteria involved in a wide spectrum of human diseases. Many virulence factors promote this widespread propagation. One important factor is acquiring antibiotic resistance genes, which leads to a reduction in the availability and efficacy of therapy options. Recently, research has suggested that the remarkable antimicrobial effect of antioxidants against superbugs such as MRSA shows synergistic effects when accompanied by antimicrobial therapy. This paper aims to examine the synergistic effects of ascorbic acid and nicotinamide with a panel of antibiotics used in antimicrobial therapy against MRSA. Material and Methods. Two SCCmec type IV MRSA reference strains (EMRSA-15 and USA300) and 10 MRSA clinical isolates feature in this paper. SCCmec typing was conducted on the 10 clinical isolates via multiplex PCR after identification. Synergy experiments on antioxidants and antibiotics were evaluated via checkerboard assay. The minimum inhibitory concentration (MIC) of each agent was determined in accordance with the Clinical and Laboratory Standards Institute (CLSI) M100 guidelines through twofold microdilution assay. Results and Discussion. Synergy (FIC PConclusion. The synergistic activity demonstrated in associating antioxidants with antibiotics shows promise in managing superbugs. However, more research is required to better understand the mechanism of the synergy and for utilization in clinical care.
- Open Access
The Effect of Ascorbic Acid and Nicotinamide on Panton–Valentine Leukocidin Cytotoxicity: An Ex Vivo Study
Background: Panton–Valentine Leukocidin sustains a strong cytotoxic activity, targeting immune cells and, consequently, perforating the plasma membrane and inducing cell death. The present study is aimed to examine the individual effect of ascorbic acid and nicotinamide on PVL cytotoxicity ex vivo, as well as their effect on granulocytes viability when treated with PVL. Materials and Methods: The PVL cytotoxicity assay was performed in triplicates using the commercial Cytotoxicity Detection Kit PLUS (LDH). LDH release was measured to determine cell damage and cell viability was measured via flow cytometry. Results and discussion: A clear reduction in PVL cytotoxicity was demonstrated (p < 0.001). Treatment with ascorbic acid at 5 mg/mL has shown a 3-fold reduction in PVL cytotoxicity; likewise, nicotinamide illustrated a 4-fold reduction in PVL cytotoxicity. Moreover, granulocytes’ viability after PVL treatment was maintained when incubated with 5 mg/mL of ascorbic acid and nicotinamide. Conclusions: our findings illustrated that ascorbic acid and nicotinamide exhibit an inhibitory effect on PVL cytotoxicity and promote cell viability, as the cytotoxic effect of the toxin is postulated to be neutralized by antioxidant incubation. Further investigations are needed to assess whether these antioxidants may be viable options in PVL cytotoxicity attenuation in PVL-associated diseases.
Open AccessThe Effect of Ascorbic Acid and Nicotinamide on Panton–Valentine Leukocidin Cytotoxicity: An Ex Vivo Study
Background: Panton–Valentine Leukocidin sustains a strong cytotoxic activity, targeting immune cells and, consequently, perforating the plasma membrane and inducing cell death. The present study is aimed to examine the individual effect of ascorbic acid and nicotinamide on PVL cytotoxicity ex vivo, as well as their effect on granulocytes viability when treated with PVL. Materials and Methods: The PVL cytotoxicity assay was performed in triplicates using the commercial Cytotoxicity Detection Kit PLUS (LDH). LDH release was measured to determine cell damage and cell viability was measured via flow cytometry. Results and discussion: A clear reduction in PVL cytotoxicity was demonstrated (p < 0.001). Treatment with ascorbic acid at 5 mg/mL has shown a 3-fold reduction in PVL cytotoxicity; likewise, nicotinamide illustrated a 4-fold reduction in PVL cytotoxicity. Moreover, granulocytes’ viability after PVL treatment was maintained when incubated with 5 mg/mL of ascorbic acid and nicotinamide. Conclusions: our findings illustrated that ascorbic acid and nicotinamide exhibit an inhibitory effect on PVL cytotoxicity and promote cell viability, as the cytotoxic effect of the toxin is postulated to be neutralized by antioxidant incubation. Further investigations are needed to assess whether these antioxidants may be viable options in PVL cytotoxicity attenuation in PVL-associated diseases.
- Open Access
- 20 December 2022
- Published by Microbiology Society
- p. 000475.v3
Synergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV Methicillin-Resistant Staphylococcus aureus (MRSA)
Background : MRSA is a pathogenic bacteria involved in a wide spectrum of human diseases. Many virulence factors promote this widespread propagation. One important factor is acquiring antibiotic resistance genes which leads to a reduction in availability and efficacy of therapy options. Recently, research suggests antioxidants remarkable antimicrobial effect against superbugs like MRSA, showing synergistic effect when accompanied by antimicrobial therapy. Henceforth, the article is aimed to examine the synergistic effect of ascorbic acid and nicotinamide with a panel of antibiotics used in antimicrobial therapy of MRSA. Material and Methods: 2 SCC mec type IV MRSA reference strains (EMRSA-15 and USA300) and 10 MRSA clinical isolates were used in this article. SCC mec typing was conducted on the 10 clinical isolates via multiplex PCR after identification. Synergy experiments of antioxidants and antibiotics were evaluated via checkerboard assay. MIC of each agent was conducted in accordance with CLSI M100 guidelines through 2-fold microdilution assay. Results and Discussion: synergy (FIC<0.5) was demonstrated for ascorbic acid (1/2-1/4 MIC) with rifampicin (1/2-1/8 MIC), also, 1/2 to 1/16 MIC of ascorbic acid when associated with vancomycin at 1/2 MIC. Similarly, nicotinamide (1/2-1/16 MIC) showed synergistic response when paired with low concentrations of rifampicin (1/2-1/16 MIC), also, when associating nicotinamide (1/4-1/16 MIC) with vancomycin (1/2 MIC). All reduced MICs due to synergistic combinations demonstrated statistical significance (P<0.05). Conclusion: The synergistic activity demonstrated in associating antioxidants and antibiotics is a promising notion in managing superbugs. However, more research required to better understand the synergy mechanism and for utilization in clinical care.
- 20 December 2022
- Published by Microbiology Society
- p. 000475.v3
Open AccessSynergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV Methicillin-Resistant Staphylococcus aureus (MRSA)
Background : MRSA is a pathogenic bacteria involved in a wide spectrum of human diseases. Many virulence factors promote this widespread propagation. One important factor is acquiring antibiotic resistance genes which leads to a reduction in availability and efficacy of therapy options. Recently, research suggests antioxidants remarkable antimicrobial effect against superbugs like MRSA, showing synergistic effect when accompanied by antimicrobial therapy. Henceforth, the article is aimed to examine the synergistic effect of ascorbic acid and nicotinamide with a panel of antibiotics used in antimicrobial therapy of MRSA. Material and Methods: 2 SCC mec type IV MRSA reference strains (EMRSA-15 and USA300) and 10 MRSA clinical isolates were used in this article. SCC mec typing was conducted on the 10 clinical isolates via multiplex PCR after identification. Synergy experiments of antioxidants and antibiotics were evaluated via checkerboard assay. MIC of each agent was conducted in accordance with CLSI M100 guidelines through 2-fold microdilution assay. Results and Discussion: synergy (FIC<0.5) was demonstrated for ascorbic acid (1/2-1/4 MIC) with rifampicin (1/2-1/8 MIC), also, 1/2 to 1/16 MIC of ascorbic acid when associated with vancomycin at 1/2 MIC. Similarly, nicotinamide (1/2-1/16 MIC) showed synergistic response when paired with low concentrations of rifampicin (1/2-1/16 MIC), also, when associating nicotinamide (1/4-1/16 MIC) with vancomycin (1/2 MIC). All reduced MICs due to synergistic combinations demonstrated statistical significance (P<0.05). Conclusion: The synergistic activity demonstrated in associating antioxidants and antibiotics is a promising notion in managing superbugs. However, more research required to better understand the synergy mechanism and for utilization in clinical care.
- Open Access
- 30 November 2022
- Published by Microbiology Society
- p. 000475.v2
Synergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV Methicillin-Resistant Staphylococcus aureus (MRSA)
Background: MRSA is a pathogenic bacteria involved in a wide spectrum of human diseases. Many virulence factors promote this widespread propagation. One important factor is acquiring antibiotic resistance genes which leads to a reduction in availability and efficacy of therapy options. Recently, research suggests antioxidants remarkable antimicrobial effect against superbugs like MRSA, showing synergistic effect when accompanied by antimicrobial therapy. Henceforth, the article is aimed to examine the synergistic effect of ascorbic acid and nicotinamide with a panel of antibiotics used in antimicrobial therapy of MRSA. Material and Methods: 2 SCCmec type IV MRSA reference strains (EMRSA-15 and USA300) and 10 MRSA clinical isolates were used in this article. SCCmec typing was conducted on the 10 clinical isolates via multiplex PCR after identification. Synergy experiments of antioxidants and antibiotics were evaluated via checkerboard assay. MIC of each agent was conducted in accordance with CLSI M100 guidelines through 2-fold microdilution assay. Results and Discussion: synergy (FIC<0.5) was demonstrated for ascorbic acid (1/2-1/4 MIC) with rifampicin (1/2-1/8 MIC), also, 1/2 to 1/16 MIC of ascorbic acid when associated with vancomycin at 1/2 MIC. Similarly, nicotinamide (1/2-1/16 MIC) showed synergistic response when paired with low concentrations of rifampicin (1/2-1/16 MIC), also, when associating nicotinamide (1/4-1/16 MIC) with vancomycin (1/2 MIC). All reduced MICs due to synergistic combinations demonstrated statistical significance (P<0.05). Conclusion: The synergistic activity demonstrated in associating antioxidants and antibiotics is a promising notion in managing superbugs. However, more research required to better understand the synergy mechanism and for utilization in clinical care.
- 30 November 2022
- Published by Microbiology Society
- p. 000475.v2
Open AccessSynergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV Methicillin-Resistant Staphylococcus aureus (MRSA)
Background: MRSA is a pathogenic bacteria involved in a wide spectrum of human diseases. Many virulence factors promote this widespread propagation. One important factor is acquiring antibiotic resistance genes which leads to a reduction in availability and efficacy of therapy options. Recently, research suggests antioxidants remarkable antimicrobial effect against superbugs like MRSA, showing synergistic effect when accompanied by antimicrobial therapy. Henceforth, the article is aimed to examine the synergistic effect of ascorbic acid and nicotinamide with a panel of antibiotics used in antimicrobial therapy of MRSA. Material and Methods: 2 SCCmec type IV MRSA reference strains (EMRSA-15 and USA300) and 10 MRSA clinical isolates were used in this article. SCCmec typing was conducted on the 10 clinical isolates via multiplex PCR after identification. Synergy experiments of antioxidants and antibiotics were evaluated via checkerboard assay. MIC of each agent was conducted in accordance with CLSI M100 guidelines through 2-fold microdilution assay. Results and Discussion: synergy (FIC<0.5) was demonstrated for ascorbic acid (1/2-1/4 MIC) with rifampicin (1/2-1/8 MIC), also, 1/2 to 1/16 MIC of ascorbic acid when associated with vancomycin at 1/2 MIC. Similarly, nicotinamide (1/2-1/16 MIC) showed synergistic response when paired with low concentrations of rifampicin (1/2-1/16 MIC), also, when associating nicotinamide (1/4-1/16 MIC) with vancomycin (1/2 MIC). All reduced MICs due to synergistic combinations demonstrated statistical significance (P<0.05). Conclusion: The synergistic activity demonstrated in associating antioxidants and antibiotics is a promising notion in managing superbugs. However, more research required to better understand the synergy mechanism and for utilization in clinical care.
- Open Access
- 15 August 2022
- Published by Microbiology Society
- p. 000475.v1
Synergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV Methicillin-Resistant Staphylococcus aureus (MRSA)
Background MRSA is a pathogenic bacteria involved in a wide spectrum of human diseases. Many virulence factors promote this widespread propagation. One important factor is acquiring antibiotic resistance genes which leads to a reduction in availability and efficacy of therapy options. Recently, research suggests antioxidants remarkable antimicrobial effect against superbugs like MRSA, showing synergistic effect when accompanied by antimicrobial therapy. Henceforth, the article is aimed to examine the synergistic effect ascorbic acid and nicotinamide with a panel of antibiotics used in antimicrobial therapy of MRSA. Material and Methods 2 SCCmec type IV MRSA reference strains (EMRSA-15 and USA300) and 10 MRSA clinical isolates were used in this article. SCCmec typing was conducted on the 10 clinical isolates via multiplex PCR after identification. Synergy of antioxidants and antibiotics were evaluated via checkerboard assay. MIC of each agent was conducted in accordance with CLSI M100 guidelines through 2-fold microdilution assay. Results and Discussion synergy (FIC<0.5) was demonstrated for ascorbic acid (1/2-1/4 MIC) with rifampicin (1/2-1/8 MIC), also, 1/2 to 1/16 MIC of ascorbic acid when associated with vancomycin at 1/2 MIC. Similarly, nicotinamide (1/2-1/16 MIC) showed synergistic response when paired with low concentrations of rifampicin (1/2-1/16 MIC), also, when associating nicotinamide (1/4-1/16 MIC) with vancomycin (1/2 MIC). Conclusion The synergistic activity demonstrated in associating antioxidants and antibiotics is a promising notion in managing superbugs. However, more research required to better understand the synergy mechanism and for utilization in clinical care.
- 15 August 2022
- Published by Microbiology Society
- p. 000475.v1
Open AccessSynergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV Methicillin-Resistant Staphylococcus aureus (MRSA)
Background MRSA is a pathogenic bacteria involved in a wide spectrum of human diseases. Many virulence factors promote this widespread propagation. One important factor is acquiring antibiotic resistance genes which leads to a reduction in availability and efficacy of therapy options. Recently, research suggests antioxidants remarkable antimicrobial effect against superbugs like MRSA, showing synergistic effect when accompanied by antimicrobial therapy. Henceforth, the article is aimed to examine the synergistic effect ascorbic acid and nicotinamide with a panel of antibiotics used in antimicrobial therapy of MRSA. Material and Methods 2 SCCmec type IV MRSA reference strains (EMRSA-15 and USA300) and 10 MRSA clinical isolates were used in this article. SCCmec typing was conducted on the 10 clinical isolates via multiplex PCR after identification. Synergy of antioxidants and antibiotics were evaluated via checkerboard assay. MIC of each agent was conducted in accordance with CLSI M100 guidelines through 2-fold microdilution assay. Results and Discussion synergy (FIC<0.5) was demonstrated for ascorbic acid (1/2-1/4 MIC) with rifampicin (1/2-1/8 MIC), also, 1/2 to 1/16 MIC of ascorbic acid when associated with vancomycin at 1/2 MIC. Similarly, nicotinamide (1/2-1/16 MIC) showed synergistic response when paired with low concentrations of rifampicin (1/2-1/16 MIC), also, when associating nicotinamide (1/4-1/16 MIC) with vancomycin (1/2 MIC). Conclusion The synergistic activity demonstrated in associating antioxidants and antibiotics is a promising notion in managing superbugs. However, more research required to better understand the synergy mechanism and for utilization in clinical care.